Alterity Therapeutics (ASX:ATH) - Webinar Presentation Company Presentations by Finance News Network February 02, 2024 04:13 PM Dr David Stamler - CEO - Alterity Therapeutics (ASX:ATH) is a clinical-stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.
